Related Experiment Videos
Cytokines in posterior uveitis: an update
1Department of Immunology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India. vksingh@sgpgi.ac.in
Insights
T helper 1 (Th1) and T helper 2 (Th2) cells have distinct cytokine profiles and roles in posterior uveitis. Shifting towards a Th2-dominant response may offer therapeutic benefits for this condition.
Area of Science:
- Immunology
- Ophthalmology
Background:
- T helper (Th) lymphocytes differentiate into Th1 and Th2 subsets, characterized by unique cytokine profiles and functional activities.
- Th1 cells secrete interferon-gamma (IFN-gamma), interleukin-2 (IL-2), and tumor necrosis factor-beta (TNF-beta), while Th2 cells produce interleukin-4 (IL-4), IL-5, IL-6, IL-9, and IL-13.
- These subsets are mutually antagonistic and play roles in the pathogenesis of posterior uveitis and experimental autoimmune uveitis (EAU).
Purpose of the Study:
- To review and evaluate studies investigating the uveitopathogenic and therapeutic potentials of Th1 and Th2 cytokines.
- To explore the role of cytokine profiles in the etiopathogenesis of posterior uveitis.
- To assess the potential therapeutic benefit of modulating Th1/Th2 responses in uveitis.
Main Methods:
- Literature review of studies examining Th1 and Th2 cytokines in the context of posterior uveitis and EAU.
- Analysis of cytokine profiles associated with Th1 and Th2 cell differentiation.
- Evaluation of research on the pathogenic and therapeutic roles of specific cytokines in uveitis models.
Main Results:
- Th1 and Th2 cells exhibit distinct cytokine profiles, functional properties, and activation markers.
- Th1 and Th2 cytokines are implicated in the pathogenesis of posterior uveitis and EAU.
- Evidence suggests a potential therapeutic advantage in shifting towards a Th2-dominated immune response in uveitis.
Conclusions:
- The balance of Th1 and Th2 cytokines is crucial in the pathogenesis of posterior uveitis.
- Modulating the Th1/Th2 immune response, particularly favoring a Th2-dominant profile, may represent a viable therapeutic strategy for uveitis.
- Further research is needed to fully define the contribution of these cytokine mediators to uveitis and to optimize therapeutic interventions.
Abstract:
T helper (Th) lymphocytes differentiate into two distinct subsets--Th1 and Th2--as defined by functional abilities and cytokine profiles. The functional differences between Th subsets are explained primarily through the activities of the cytokines they secrete. Interferon-gamma (IFN-gamma) is the signature cytokine of Th1 cells, which also produce interleukin-2 (IL-2) and tumor necrosis factor-beta (TNF-beta). IL-4 is the corresponding signature cytokine of Th2 cells, which also secrete IL-5, IL-6, IL-9, and IL-13. Recently, a few transcription factors have been identified that not only control the expression of cytokines of a particular type but also repress cytokines of other types. Human Th1 and Th2 cells not only produce a different set of cytokines but also exhibit distinct functional properties and the preferential expression of some activation markers. Pathophysiologically, the two subsets have been found to be mutually antagonistic. Various Th1 and Th2 cytokines appear to play an important role in the etiopathogenesis of posterior uveitis and its animal model, experimental autoimmune uveitis (EAU). The exact contribution of these mediators to uveitis remains to be defined. Recent studies suggest that a shift from Th1- to Th2-dominated response could be of therapeutic benefit. This review evaluates various studies in which uveitopathogenic and therapeutic potentials of various Th1 and Th2 cytokines have been investigated.